{"aliases":[{"type":"CASRegistryName","name":"461432-26-8"},{"type":"CodeName","name":"BMS-512148-05"},{"type":"ChemicalStructureName","name":"D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)"}],"definition":{"html":"A selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Dapagliflozin selectively and potently inhibits SGLT2 compared to SGLT1, which is the cotransporter of glucose in the gut.","text":"A selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Dapagliflozin selectively and potently inhibits SGLT2 compared to SGLT1, which is the cotransporter of glucose in the gut."},"drugInfoSummaryLink":null,"nciConceptId":"C78126","nciConceptName":"Dapagliflozin","termId":802820,"name":"dapagliflozin","firstLetter":"d","type":"DrugTerm","termNameType":"PreferredName","prettyUrlName":"dapagliflozin"}